ATE67667T1 - Neue topische metronidazol-formulierungen. - Google Patents

Neue topische metronidazol-formulierungen.

Info

Publication number
ATE67667T1
ATE67667T1 AT87902908T AT87902908T ATE67667T1 AT E67667 T1 ATE67667 T1 AT E67667T1 AT 87902908 T AT87902908 T AT 87902908T AT 87902908 T AT87902908 T AT 87902908T AT E67667 T1 ATE67667 T1 AT E67667T1
Authority
AT
Austria
Prior art keywords
formulations
drug
new topical
topical metronidazole
topical formulations
Prior art date
Application number
AT87902908T
Other languages
English (en)
Inventor
Robert John Borgman
Original Assignee
Curatek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22202320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE67667(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Curatek Pharmaceuticals filed Critical Curatek Pharmaceuticals
Application granted granted Critical
Publication of ATE67667T1 publication Critical patent/ATE67667T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Cosmetics (AREA)
AT87902908T 1987-03-20 1987-03-20 Neue topische metronidazol-formulierungen. ATE67667T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1987/000584 WO1988006888A1 (en) 1987-03-20 1987-03-20 Novel topical metronidazole formulations and therapeutic uses thereof
EP87902908A EP0305380B1 (de) 1987-03-20 1987-03-20 Neue topische metronidazol-formulierungen

Publications (1)

Publication Number Publication Date
ATE67667T1 true ATE67667T1 (de) 1991-10-15

Family

ID=22202320

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87902908T ATE67667T1 (de) 1987-03-20 1987-03-20 Neue topische metronidazol-formulierungen.

Country Status (10)

Country Link
EP (1) EP0305380B1 (de)
JP (1) JPH0825878B2 (de)
KR (1) KR950003919B1 (de)
AT (1) ATE67667T1 (de)
AU (1) AU610495B2 (de)
DE (1) DE3773383D1 (de)
DK (1) DK173844B1 (de)
FI (1) FI88582C (de)
NO (1) NO175883C (de)
WO (1) WO1988006888A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
US4859694A (en) * 1988-02-10 1989-08-22 Pavlich Frederick M Method for treating hoof thrush and hoof rot
GB8910076D0 (en) † 1989-05-03 1989-06-21 Thackray C F Ltd Sterilisable lubricant
SE506509C2 (sv) * 1992-04-14 1997-12-22 Bioglan Ab Användning av imidazoler för framställning av en farmaceutisk formulering för behandling av inflammatoriska och/eller infektiösa hudsjukdomar
FR2722098B1 (fr) * 1994-07-06 1996-08-23 Cird Galderma Nouveaux medicaments a base de metro-nidazole ou d'un melange synergetique de metronidazole et de clindamycine
GB9415290D0 (en) 1994-07-28 1994-09-21 Zeneca Ltd Gel formation
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
US6468989B1 (en) * 2000-07-13 2002-10-22 Dow Pharmaceutical Sciences Gel compositions containing metronidazole
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US20060093675A1 (en) * 2004-10-29 2006-05-04 Mathew Ebmeier Intravaginal treatment of vaginal infections with metronidazole compositions
FR2882552B1 (fr) * 2005-02-25 2008-12-26 Galderma Sa Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation
PL2544532T3 (pl) 2010-03-12 2017-08-31 Monsanto Technology Llc Agrochemiczne kompozycje żelowe
AU2012275292B2 (en) 2011-06-28 2015-11-12 Chemo Research, S.L. High dosage mucoadhesive metronidazole aqueous-based gel formulations their use to treat bacterial vaginosis
EP3013368A1 (de) 2013-06-25 2016-05-04 Mission Pharmacal Company Neuartige formulierungen zur behandlung von vaginalen erkrankungen
EP3641725A1 (de) 2017-06-23 2020-04-29 The Procter and Gamble Company Zusammensetzung und verfahren zur verbesserung der erscheinung der haut
US11622963B2 (en) 2018-07-03 2023-04-11 The Procter & Gamble Company Method of treating a skin condition
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
CN115843238B (zh) 2020-06-01 2025-06-10 宝洁公司 改善维生素b3化合物渗透到皮肤中的方法
WO2022269665A1 (ja) * 2021-06-21 2022-12-29 マルホ株式会社 外用剤
CN115350144A (zh) * 2022-07-28 2022-11-18 苏州弘森药业股份有限公司 一种甲硝唑水凝胶及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883661A (en) * 1971-11-09 1975-05-13 Syntex Inc Acne treatment
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment

Also Published As

Publication number Publication date
AU610495B2 (en) 1991-05-23
WO1988006888A1 (en) 1988-09-22
NO175883B (no) 1994-09-19
DE3773383D1 (de) 1991-10-31
DK645488D0 (da) 1988-11-18
DK173844B1 (da) 2001-12-10
FI88582B (fi) 1993-02-26
DK645488A (da) 1989-01-19
NO175883C (no) 1994-12-28
FI885377A0 (fi) 1988-11-18
EP0305380A4 (de) 1989-06-26
EP0305380B1 (de) 1991-09-25
FI885377L (fi) 1988-11-18
KR890701113A (ko) 1989-12-19
JPH0825878B2 (ja) 1996-03-13
FI88582C (fi) 1993-06-10
NO885172D0 (no) 1988-11-18
JPH01503061A (ja) 1989-10-19
NO885172L (no) 1988-11-18
AU7233787A (en) 1988-10-10
KR950003919B1 (ko) 1995-04-20
EP0305380A1 (de) 1989-03-08

Similar Documents

Publication Publication Date Title
FI885377A0 (fi) Foerfarande foer framstaellning av nya metronidazolsammansaettningar foer lokal administration.
ZA89233B (en) Topical metronidazole formulations and therapeutic uses thereof
HUP9801234A2 (hu) Nitroglicerint tartalmazó, vizes alapú, helyileg alkalmazható krém, eljárás előállítására és alkalmazása
FR2347044A1 (fr) Compositions pharmaceutiques contenant comme ingredients actifs des derives de triazolo-pyrimidines utiles pour le traitement de psoriasis
ATE98652T1 (de) Chemische derivate von ghl-cu.
DK165440C (da) Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele
FR2544984B1 (fr) Pommade dermique et dermatologique a large spectre d'activite, et son procede de preparation
FR2562539B1 (fr) Nouveaux derives de l'acide vinyl-4 benzoique, leur procede de preparation et leurs applications en therapeutique et comme ligands
BR9913589A (pt) Composição, e, processo cosmético para reduzir ardência ou irritação induzidas pela aplicação tópica de uma composição
DK163911C (da) Indomethacinholdig gelagtig salve
EP0249736A3 (de) Salbe zur Behandlung von Hauterkrankungen
DK284386A (da) Farmaceutisk praeparat mod hudlidelser
KR930012013A (ko) 건선과 과민성 피부염 치료에 국소적으로 사용되는 제약학적 성분물
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
ATE98868T1 (de) Topisch kosmetisch anzuwendende depolymerisierte nukleinsaeuren enthaltende arzneizubereitungen.
SE9801647D0 (sv) Therapeutic composition
KR910005876A (ko) 모세혈관 취약증의 치료를 위한 극소용 약학적 조성물
DK227090A (da) Organisk guldkompleks til topisk anvendelse
BR9408023A (pt) Formulações de fenbendazol
ES2137125B1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
IE45054L (en) Veterinary composition
FI861329L (fi) Anvaendning av 4-(isoxazolyl)-tiazol-2-oxaminsyraderivat.
ATE271896T1 (de) Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis
PT1232173E (pt) Derivados do acido fusidico
EP0252033A2 (de) N-(2,6-Dichlor-m-tolyl)anthranilsäure (Mechlophenaminsäure) enthaltenden Gel-Arzneiform zur Verwendung in der Lokaltherapie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties